{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T14:56:29Z","timestamp":1782831389783,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.clnu.2024.12.011","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T01:04:13Z","timestamp":1734397453000},"page":"193-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Renin-independent aldosteronism and metabolic dysfunction-associated steatotic liver disease and cirrhosis: A genetic association study"],"prefix":"10.1016","volume":"44","author":[{"given":"Qinglian","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2024.12.011_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","article-title":"Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons","volume":"79","author":"Le","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2024.12.011_bib2","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jhep.2023.01.024","article-title":"An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease","volume":"78","author":"Lee","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2024.12.011_bib3","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A\u00a0multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2024.12.011_bib4","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","article-title":"99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical","volume":"80","author":"Hagstr\u00f6m","year":"2024","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2024.12.011_bib5","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-22-0249","article-title":"Mineralocorticoid receptor signalling in primary aldosteronism","volume":"259","author":"Yang","year":"2023","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.clnu.2024.12.011_bib6","doi-asserted-by":"crossref","first-page":"E1415","DOI":"10.1152\/ajpendo.00419.2013","article-title":"Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet","volume":"305","author":"Wada","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.clnu.2024.12.011_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118619","article-title":"Significance of MR\/OPN\/HMGB1 axis in NAFLD-associated hepatic fibrogenesis","volume":"264","author":"Tang","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.clnu.2024.12.011_bib8","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1111\/bph.15784","article-title":"Mineralocorticoid receptors in non-alcoholic fatty liver disease","volume":"179","author":"Schreier","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clnu.2024.12.011_bib9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1111\/liv.12794","article-title":"Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis","volume":"35","author":"Pizarro","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.clnu.2024.12.011_bib10","first-page":"346","article-title":"Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease","volume":"48","author":"Papaefthymiou","year":"2021","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.clnu.2024.12.011_bib11","first-page":"407","article-title":"Selective aldosterone blocker ameliorates the progression of non-alcoholic steatohepatitis in rats","volume":"26","author":"Noguchi","year":"2010","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.clnu.2024.12.011_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.563434","article-title":"A\u00a0mineralocorticoid receptor deficiency in myeloid cells reduces liver steatosis by impairing activation of CD8(+) T cells in a nonalcoholic steatohepatitis mouse model","volume":"11","author":"Mu\u00f1oz-Durango","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.clnu.2024.12.011_bib13","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/dom.12989","article-title":"Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial","volume":"19","author":"Polyzos","year":"2017","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.clnu.2024.12.011_bib14","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.clnu.2024.12.011_bib15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study","volume":"167","author":"Brown","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clnu.2024.12.011_bib16","article-title":"Heightened cardiovascular risk in hypertension associated with renin-independent aldosteronism versus renin-dependent aldosteronism: a collaborative study","volume":"10","author":"Hu","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.clnu.2024.12.011_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155593","article-title":"Renin-independent aldosteronism and chronic kidney disease in diabetes: observational and Mendelian randomization analyses","volume":"145","author":"Hu","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.clnu.2024.12.011_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1210\/endrev\/bnad026","article-title":"Treating primary aldosteronism-induced hypertension: novel approaches and future outlooks","volume":"45","author":"Mullen","year":"2024","journal-title":"Endocr Rev"},{"key":"10.1016\/j.clnu.2024.12.011_bib19","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s41581-023-00753-6","article-title":"Primary aldosteronism: molecular medicine meets public health","volume":"19","author":"Azizan","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.clnu.2024.12.011_bib20","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2147\/DMSO.S408722","article-title":"Relationship between plasma aldosterone concentrations and non-alcoholic fatty liver disease diagnosis in patients with hypertension: a retrospective cohort study","volume":"16","author":"Hu","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.clnu.2024.12.011_bib21","article-title":"Non-alcoholic fatty liver disease and hypokalemia in primary aldosteronism among Chinese population","volume":"12","author":"Chen","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.clnu.2024.12.011_bib22","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","article-title":"Multiomics study of nonalcoholic fatty liver disease","volume":"54","author":"Sveinbjornsson","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.clnu.2024.12.011_bib23","article-title":"Body mass index and all cause mortality in HUNT and UK Biobank studies: linear and non-linear mendelian randomisation analyses","volume":"364","author":"Sun","year":"2019","journal-title":"Br Med J"},{"key":"10.1016\/j.clnu.2024.12.011_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12916-023-02793-y","article-title":"Associations between an inflammatory diet index and severe non-alcoholic fatty liver disease: a prospective study of 171,544 UK Biobank participants","volume":"21","author":"Petermann-Rocha","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.clnu.2024.12.011_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008629","article-title":"A\u00a0missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease","volume":"16","author":"Emdin","year":"2020","journal-title":"PLoS Genet"},{"key":"10.1016\/j.clnu.2024.12.011_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.clnu.2024.12.011_bib27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","article-title":"Guidelines for performing Mendelian randomization investigations: update for summer 2023","volume":"4","author":"Burgess","year":"2019","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.clnu.2024.12.011_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ajh.2009.206","article-title":"Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study","volume":"23","author":"Fallo","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.clnu.2024.12.011_bib29","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.clnu.2024.12.011_bib30","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.jacc.2018.07.079","article-title":"Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention","volume":"72","author":"Inouye","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clnu.2024.12.011_bib31","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/s41591-022-01767-6","article-title":"Development of a clinical polygenic risk score assay and reporting workflow","volume":"28","author":"Hao","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.clnu.2024.12.011_bib32","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1038\/s41467-022-32896-8","article-title":"Identification of risk loci for primary aldosteronism in genome-wide association studies","volume":"13","author":"Le Floch","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.clnu.2024.12.011_bib33","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/HYPERTENSIONAHA.116.07564","article-title":"KCNK3 variants are associated with hyperaldosteronism and hypertension","volume":"68","author":"Manichaikul","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.clnu.2024.12.011_bib34","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/HYPERTENSIONAHA.113.02504","article-title":"Diastrophic dysplasia sulfate transporter (SLC26A2) is expressed in the adrenal cortex and regulates aldosterone secretion","volume":"63","author":"Spyroglou","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.clnu.2024.12.011_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.clnu.2024.12.011_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.123.066389","article-title":"Subclinical primary aldosteronism and cardiovascular health: a population-based cohort study","volume":"149","author":"Hundemer","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.clnu.2024.12.011_bib37","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.clnu.2024.12.011_bib38","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S2215-0366(21)00286-8","article-title":"Associations between plasma fatty acid concentrations and schizophrenia: a two-sample Mendelian randomisation study","volume":"8","author":"Jones","year":"2021","journal-title":"Lancet Psychiatr"},{"key":"10.1016\/j.clnu.2024.12.011_bib39","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.biopsych.2022.08.012","article-title":"The relationship of attention-deficit\/hyperactivity disorder with posttraumatic stress disorder: a two-sample mendelian randomization and population-based sibling comparison study","volume":"93","author":"Wendt","year":"2022","journal-title":"Biol Psychiatr"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424004527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424004527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T23:41:10Z","timestamp":1736206870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561424004527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":39,"alternative-id":["S0261561424004527"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2024.12.011","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renin-independent aldosteronism and metabolic dysfunction-associated steatotic liver disease and cirrhosis: A genetic association study","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2024.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}